5/5/2010
FDA RECOMMENDS NEW DOSING FOR COLCRYS® (COLCHICINE, USP) WHEN COADMINISTERED WITH PROTEASE INHIBITORS
Read More
3/31/2010
COLCRYS® (COLCHICINE, USP) SHOWS SUPERIOR SAFETY WITH COMPARABLE EFFICACY COMPARED TO HIGH-DOSE COLCHICINE IN TREATMENT OF EARLY ACUTE GOUT FLARES
Study Published in April Issue of Arthritis & Rheumatism
Read More
3/15/2010
URL PHARMA EXPANDS COLCRYS® PATIENT ASSISTANCE PROGRAM
Gout and FMF Patients with Income Up to Six Times Federal Poverty Level Now Eligible for Assistance
Read More